Aurisco Pharmaceutical Competitors and Similar CompaniesClear all

Aurisco Pharmaceutical's competitors and similar companies include Sun Pharma, Torrent Pharmaceuticals, Hikma Pharmaceuticals and KRKA.

	Aurisco Pharmaceutical Aurisco Pharmaceutical (澳瑞科藥業有限公司) is a pharmaceutical company engaged in the research, manufacturing, and marketing of active pharmaceutical ingredients (APIs).	Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.	Torrent Pharmaceuticals Manufactures wide range of pharmaceutical products.	Hikma Pharmaceuticals Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.	KRKA KRKA is an international generic pharmaceutical company.
Founding Date	Founding Date 1998	Founding Date 1983	Founding Date 1971	Founding Date 1978	Founding Date 1954
Type	Type Public	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare pharma	Tags Healthcare drug development pharma	Tags Healthcare pharma	Tags Healthcare pharma	Tags Healthcare pharma
Locations	Locations Shanghai, CN HQ	Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more	Locations Ahmedabad, IN HQ São Paulo, BR Nürnberg, DE 32 No Market, IN Bengaluru, IN Chennai, IN Dahej, IN see more	Locations London, GB HQ Staoueli, DZ Mississauga, CA Boulogne Billancourt, FR Martinsried, DE Pavia, IT Amman, JO see more	Locations SI HQ
Employees	Employees 1,784	Employees 43,000	Employees 15,718	Employees 9,500	Employees 132,447
Valuation ($)	Valuation ($) 1.3 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 5.6 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) ¥1.7b (FY, 2025)	Revenue (est.) ₹582.2b (FY, 2026)	Revenue (est.) ₹137.5b (FY, 2026)	Revenue (est.) $3.3b (FY, 2025)	Revenue (est.) €2b (FY, 2025)
Cost of goods	Cost of goods ¥684.6m (FY, 2025)	Cost of goods ₹115.4b (FY, 2026)	Cost of goods ₹33.9b (FY, 2026)	Cost of goods $1.7b (FY, 2025)	Cost of goods €764m (FY, 2025)
Gross profit	Gross profit ¥997.1m (FY, 2025)	Gross profit ₹488.9b (FY, 2026)	Gross profit ₹105b (FY, 2026)	Gross profit $1.7b (FY, 2025)	Gross profit €1.3b (FY, 2025)
Net income	Net income ¥449.2m (FY, 2025)	Net income ₹115.6b (FY, 2026)	Net income ₹21.4b (FY, 2026)	Net income $407m (FY, 2025)	Net income €403.7m (FY, 2025)